Can a Once-Weekly pill clear stubborn psoriasis?
NCT ID NCT07765628
First seen Aug 14, 2026 · Last updated Aug 14, 2026
Summary
This phase 2 trial is testing whether an experimental oral drug called HS-20118 can improve moderate to severe plaque psoriasis, a condition that causes thick, scaly patches on the skin. About 120 adults with the condition will receive either HS-20118 or a placebo once a week for 16 weeks. The main goal is to see if the drug leads to at least a 75% improvement in psoriasis severity, as measured by a standard scoring system.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- HS-20118, an oral drug taken once weekly
- What this could lead to
- If successful, this could lead to a new once-weekly pill to help clear skin in people with moderate to severe plaque psoriasis.
- What could go wrong
- This is an early-phase trial with a modest number of participants, so results may not hold up in larger studies. As with any new drug, there may be side effects not yet known.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MODERATE TO SEVERE PLAQUE PSORIASIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- New oral pill aims to clear psoriasis in major trial
- New biologic drug netakimab tested in kids with psoriasis
- New study monitors how fast psoriasis drugs work in daily life
- New psoriasis drug shows promise for teens in early trial
- Could a diabetes drug boost psoriasis treatment in overweight patients?
- New pill could clear psoriasis in thousands